Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group

By van Wijk F.H.   Lhomme C.   Bolis G.   Scotto di Palumbo V.   Tumolo S.   Nooij M.   de Oliveira C.F.   Vermorken J.B.  

European Journal of Cancer, Vol. 39, Iss. 1, 2003-01 ,pp. : 78-85

Elsevier

Access to resources Recommend Favorite

Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study

By Covens A.   Brunetto V.L.   Markman M.   Orr J.W.   Lentz S.S.   Benda J.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 470-474

Elsevier

Access to resources Recommend Favorite

A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer

By McMeekin D.S.   Gordon A.   Fowler J.   Melemed A.   Buller R.   Burke T.   Bloss J.   Sabbatini P.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 64-69

Elsevier

Access to resources Recommend Favorite

A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G.   Brunetto V.L.   VanLe L.   Bell J.   Walker J.L.   Lee R.B.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 212-216

Elsevier

Access to resources Recommend Favorite

Treatment of Advanced or Recurrent Endometrial Carcinoma with Combination of Etoposide, Cisplatin, and 5-Fluorouracil: A Phase II Study

By Pierga J.Y.   Dieras V.   Paraiso D.   Dorval T.   Palangie T.   Beuzeboc P.   Jouve M.   Scholl S.M.   Garcia-Giralt E.   Pouillart P.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 59-63

Academic Press

Access to resources Recommend Favorite